Genetically-Engineered Malaria Vaccines Show Promise in the Clinic

May 22, 2020

(Chemical & Engineering News) – Two experimental malaria vaccines have delivered promising results in first-in-human trials, demonstrating how genetic engineering is driving a new wave of vaccines that could protect people from this killer disease. The World Health Organization estimates that there are more than 200 million cases of malaria each year, causing almost half a million deaths. Although malaria can be treated with drugs, researchers have spent decades trying to develop vaccines that could prevent and potentially even help eradicate malaria.